Labrini Papanastasiou Selected Research

Labrini Papanastasiou Research Topics

Disease

9	Hypertension (High Blood Pressure) 12/2022 - 04/2012
7	Hyperaldosteronism (Conn Syndrome) 06/2020 - 04/2013
4	Adenoma (Adenomas) 01/2017 - 04/2012
3	Neoplasms (Cancer) 12/2022 - 04/2014
3	Pheochromocytoma 12/2022 - 11/2012
3	Essential Hypertension 09/2022 - 05/2015
2	Non-alcoholic Fatty Liver Disease 06/2017 - 11/2012
2	Infections 04/2016 - 10/2012
1	Hypotension (Low Blood Pressure) 12/2022
1	Takotsubo Cardiomyopathy 12/2022
1	Lymphoma (Lymphomas) 01/2022
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 06/2021
1	Ketosis 06/2021
1	Acidosis 06/2021
1	Thyroid Neoplasms (Thyroid Cancer) 04/2021
1	Hyperkalemia 06/2020
1	Morbid Obesity 01/2020
1	Vitamin D Deficiency 01/2020
1	Osteomalacia 01/2020
1	Stress Fractures (Stress Fracture) 01/2020
1	Endometriosis 01/2017
1	Female Infertility 01/2017
1	Adrenal incidentaloma 01/2017
1	Autoimmune Hypophysitis 04/2016
1	Diabetes Mellitus 10/2015
1	Hypersensitivity (Allergy) 08/2015
1	Prehypertension 05/2015
1	Hyperplasia 05/2015
1	Insulinoma 04/2015
1	Hypoglycemia (Reactive Hypoglycemia) 04/2015
1	Hyperinsulinism (Hyperinsulinemia) 04/2015
1	Prolactinoma (Prolactinomas) 04/2014
1	Insulin Resistance 11/2012
1	Abdominal Obesity 11/2012
1	Seizures (Absence Seizure) 10/2012
1	Pain (Aches) 11/2011
1	Hypophosphatemia 11/2011
1	Familial Hypophosphatemia (Phosphate Diabetes) 11/2011
1	Muscle Weakness 11/2011
1	Pituitary Neoplasms (Pituitary Adenoma) 01/2010
1	Paralysis (Palsy) 01/2010
1	Hyperthyroidism 01/2010
1	Hypokalemia 01/2010
1	Autoimmune Diseases (Autoimmune Disease) 08/2007

Drug/Important Bio-Agent (IBA)

10	AldosteroneIBA 09/2022 - 04/2012
4	Hydrocortisone (Cortisol)FDA LinkGeneric 06/2017 - 11/2012
3	Adrenocorticotropic Hormone (ACTH)FDA Link 09/2022 - 05/2015
3	ReninIBA 01/2022 - 08/2015
2	PotassiumIBA 01/2022 - 04/2013
2	Glucose (Dextrose)FDA LinkGeneric 06/2021 - 11/2012
2	Mineralocorticoid Receptor AntagonistsIBA 06/2020 - 08/2015
2	GlucocorticoidsIBA 06/2017 - 04/2016
1	Vasodilator Agents (Vasodilators)IBA 12/2022
1	Vasoconstrictor AgentsIBA 12/2022
1	CatecholaminesIBA 12/2022
1	Phenoxybenzamine FDA Link 12/2022
1	Valsartan (Vals)FDA Link 09/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 09/2022
1	Captopril (Capoten)FDA LinkGeneric 09/2022
1	Methotrexate (Mexate)FDA LinkGeneric 01/2022
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2022
1	SodiumIBA 06/2021
1	Sodium-Glucose Transporter 2 InhibitorsIBA 06/2021
1	Tyrosine Kinase InhibitorsIBA 04/2021
1	SaltsIBA 06/2020
1	CalciumIBA 01/2020
1	Ergocalciferols (Ergocalciferol)FDA LinkGeneric 01/2020
1	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 10/2017
1	EnzymesIBA 06/2017
1	Adrenergic Agents (Adrenergic Drugs)IBA 06/2017
1	AndrogensIBA 06/2017
1	Cortisone FDA Link 06/2017
1	Dehydroepiandrosterone (DHEA)IBA 06/2017
1	Oxidoreductases (Dehydrogenase)IBA 06/2017
1	Vitamin D FDA LinkGeneric 01/2017
1	Azathioprine (Imuran)FDA LinkGeneric 04/2016
1	Blood Glucose (Blood Sugar)IBA 10/2015
1	Insulin (Novolin)FDA Link 10/2015
1	Hormones (Hormone)IBA 04/2015
1	Diazoxide (Hyperstat)FDA Link 04/2015
1	ProlactinIBA 04/2014
1	Cabergoline FDA LinkGeneric 04/2014
1	Dopamine Agonists (Dopamine Agonist)IBA 04/2014
1	Triglycerides (Triacylglycerol)IBA 11/2012
1	Parathyroid Hormone (Parathormone)IBA 11/2011
1	Fibroblast Growth Factor-23IBA 11/2011
1	Cinacalcet (Sensipar)FDA Link 11/2011
1	Calcitriol (Calcijex)FDA LinkGeneric 11/2011
1	Thyroid HormonesIBA 01/2010
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2010
1	AntibodiesIBA 08/2007
1	EpitopesIBA 08/2007
1	IodineIBA 08/2007

Therapy/Procedure

3	Therapeutics 11/2014 - 04/2014
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2020
1	Bariatric Surgery 01/2020
1	Adrenalectomy 10/2017
1	Glycemic Control 10/2015
1	Drug Therapy (Chemotherapy) 10/2012